281 related articles for article (PubMed ID: 23321250)
1. SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.
Vegliante MC; Palomero J; Pérez-Galán P; Roué G; Castellano G; Navarro A; Clot G; Moros A; Suárez-Cisneros H; Beà S; Hernández L; Enjuanes A; Jares P; Villamor N; Colomer D; Martín-Subero JI; Campo E; Amador V
Blood; 2013 Mar; 121(12):2175-85. PubMed ID: 23321250
[TBL] [Abstract][Full Text] [Related]
2. SOX11 is a mantle cell lymphoma oncogene.
Ferrando AA
Blood; 2013 Mar; 121(12):2169-70. PubMed ID: 23520328
[No Abstract] [Full Text] [Related]
3. Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma.
Wang X; Björklund S; Wasik AM; Grandien A; Andersson P; Kimby E; Dahlman-Wright K; Zhao C; Christensson B; Sander B
PLoS One; 2010 Nov; 5(11):e14085. PubMed ID: 21124928
[TBL] [Abstract][Full Text] [Related]
4. SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma.
Balsas P; Palomero J; Eguileor Á; Rodríguez ML; Vegliante MC; Planas-Rigol E; Sureda-Gómez M; Cid MC; Campo E; Amador V
Blood; 2017 Jul; 130(4):501-513. PubMed ID: 28533307
[TBL] [Abstract][Full Text] [Related]
5. [Relationship of Expression Between SOX11 and PAX5 in Pathological Tissue Specimens of Patients with Mantle Cell Lymphoma and Its Clinical Significance].
Jing CX; Feng Y; Cao X; Xu CG
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):355-360. PubMed ID: 32543142
[TBL] [Abstract][Full Text] [Related]
6. SOX11 augments BCR signaling to drive MCL-like tumor development.
Kuo PY; Jatiani SS; Rahman AH; Edwards D; Jiang Z; Ahr K; Perumal D; Leshchenko VV; Brody J; Shaknovich R; Ye BH; Parekh S
Blood; 2018 May; 131(20):2247-2255. PubMed ID: 29615403
[TBL] [Abstract][Full Text] [Related]
7. Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype.
Ribera-Cortada I; Martinez D; Amador V; Royo C; Navarro A; Beà S; Gine E; de Leval L; Serrano S; Wotherspoon A; Colomer D; Martinez A; Campo E
Mod Pathol; 2015 Nov; 28(11):1435-47. PubMed ID: 26360498
[TBL] [Abstract][Full Text] [Related]
8. SOX11, a key oncogenic factor in mantle cell lymphoma.
Beekman R; Amador V; Campo E
Curr Opin Hematol; 2018 Jul; 25(4):299-306. PubMed ID: 29738333
[TBL] [Abstract][Full Text] [Related]
9. SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma.
Palomero J; Vegliante MC; Rodríguez ML; Eguileor A; Castellano G; Planas-Rigol E; Jares P; Ribera-Cortada I; Cid MC; Campo E; Amador V
Blood; 2014 Oct; 124(14):2235-47. PubMed ID: 25092176
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma.
Jing C; Zheng Y; Feng Y; Cao X; Xu C
Sci Rep; 2021 Jun; 11(1):11896. PubMed ID: 34099776
[TBL] [Abstract][Full Text] [Related]
11. SOX11 regulates the pro-apoptosis signal pathway and predicts a favorable prognosis of mantle cell lymphoma.
Yang W; Wang Y; Yu Z; Li Z; An G; Liu W; Lv R; Ma L; Yi S; Qiu L
Int J Hematol; 2017 Aug; 106(2):212-220. PubMed ID: 28429312
[TBL] [Abstract][Full Text] [Related]
12. Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo.
Conrotto P; Andréasson U; Kuci V; Borrebaeck CA; Ek S
Mol Oncol; 2011 Dec; 5(6):527-37. PubMed ID: 21880559
[TBL] [Abstract][Full Text] [Related]
13. SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression.
Wasik AM; Lord M; Wang X; Zong F; Andersson P; Kimby E; Christensson B; Karimi M; Sander B
Sci Rep; 2013; 3():1400. PubMed ID: 23466598
[TBL] [Abstract][Full Text] [Related]
14. MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via directly targeting SOX11.
Wu B; Li J; Wang H; Wu Q; Liu H
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2197-2208. PubMed ID: 32040593
[TBL] [Abstract][Full Text] [Related]
15. [Expression of SOX11 transcription factor. Its implication in mantle cell lymphoma].
Roisman A; Slavutsky I
Medicina (B Aires); 2014; 74(2):140-6. PubMed ID: 24736261
[TBL] [Abstract][Full Text] [Related]
16. High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma.
Kuo PY; Leshchenko VV; Fazzari MJ; Perumal D; Gellen T; He T; Iqbal J; Baumgartner-Wennerholm S; Nygren L; Zhang F; Zhang W; Suh KS; Goy A; Yang DT; Chan WC; Kahl BS; Verma AK; Gascoyne RD; Kimby E; Sander B; Ye BH; Melnick AM; Parekh S
Oncogene; 2015 Mar; 34(10):1231-40. PubMed ID: 24681958
[TBL] [Abstract][Full Text] [Related]
17. Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma.
Mohanty A; Sandoval N; Phan A; Nguyen TV; Chen RW; Budde E; Mei M; Popplewell L; Pham LV; Kwak LW; Weisenburger DD; Rosen ST; Chan WC; Müschen M; Ngo VN
Blood; 2019 Jan; 133(4):306-318. PubMed ID: 30530749
[TBL] [Abstract][Full Text] [Related]
18. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma.
Ek S; Dictor M; Jerkeman M; Jirström K; Borrebaeck CA
Blood; 2008 Jan; 111(2):800-5. PubMed ID: 17934069
[TBL] [Abstract][Full Text] [Related]
19. Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1.
Teo AE; Chen Z; Miranda RN; McDonnell T; Medeiros LJ; McCarty N
Leukemia; 2016 Mar; 30(3):580-93. PubMed ID: 26073757
[TBL] [Abstract][Full Text] [Related]
20. SOX11 expression in mantle cell lymphoma.
Xu W; Li JY
Leuk Lymphoma; 2010 Nov; 51(11):1962-7. PubMed ID: 20919851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
